Personal information

No personal information available

Activities

Collapse all

Works (10)

Recomendaciones sobre el tratamiento farmacológico del cáncer de ovario epitelial en México

Gaceta Médica de México
2023-03-28 | Journal article
DOI: 10.24875/gmm.m21000569
Part of ISSN: 0016-3813
Contributors: Dolores Gallardo-Rincón; Antonio Bahena-Gonzalez; Rosa M. Álvarez; Eva M. Gómez-García; Patricia Cortés-Esteban; Ricardo Villalobos-Valencia; Carlos A. Hernández-Hernández; Andrés de J. Morán-Mendoza; Rosa A. Salcedo-Hernández; Lucely del C. Cetina-Pérez
Source: Self-asserted source
Antonio Bahena-Gonzalez

Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12

Frontiers in Genetics
2022-06-06 | Journal article
DOI: 10.3389/fgene.2022.863956
Part of ISSN: 1664-8021
Contributors: Dolores Gallardo-Rincón; Edgar Montes-Servín; Gabriela Alamilla-García; Elizabeth Montes-Servín; Antonio Bahena-Gonzalez; Lucely Cetina-Pérez; Flavia Morales Vásquez; Claudia Cano-Blanco; Jaime Coronel-Martínez; Ernesto González-Ibarra et al.
Source: Self-asserted source
Antonio Bahena-Gonzalez

Impact of metabolic syndrome on the risk of endometrial cancer and the role of lifestyle in prevention

Bosnian Journal of Basic Medical Sciences
2022-02-27 | Journal article
DOI: 10.17305/bjbms.2021.6963
Part of ISSN: 1840-4812
Part of ISSN: 1512-8601
Contributors: Alejandra Rocío Pérez Martín; Angel Denisse Castro-Eguiluz; Lucely Cetina; Yadira Velasco; Antonio Bahena-Gonzalez; Edgar Montes-Servín; Ernesto González-Ibarra; Raquel Espinoza-Romero; DOLORES GALLARDO-RINCÓN
Source: Self-asserted source
Antonio Bahena-Gonzalez

Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first- or second-generation EGFR-TKIs

Cancer Biomarkers
2021-09-24 | Journal article
DOI: 10.3233/cbm-203164
Part of ISSN: 1875-8592
Part of ISSN: 1574-0153
Contributors: Oscar Arrieta; Juan-Manuel Hernandez-Martinez; Edgar Montes-Servín; David Heredia; Andrés F. Cardona; Camilo Molina-Romero; Luis Lara-Mejía; Diego Diaz-Garcia; Antonio Bahena-Gonzalez; Dolores L. Mendoza-Oliva
Source: Self-asserted source
Antonio Bahena-Gonzalez

Validation of the QLQ-EN24 instrument for the assessment of health-related quality of life for women with endometrial cancer in México

Archives of Gynecology and Obstetrics
2021-09-13 | Journal article
DOI: 10.1007/s00404-021-05990-3
Contributors: Dolores Gallardo-Rincón; Alfredo Toledo-Leyva; Antonio Bahena-González; Elizabeth Montes-Servín; Alejandra Rocío Pérez-Martín; Edgar Montes-Servín; Gabriela C. Alamilla-García; D. Darlene Carmona-Herrera; Jaime Coronel-Martínez; Luis F. Oñate-Ocaña
Source: check_circle
Crossref

PARP inhibitors in ovarian cancer: evidence for maintenance and treatment strategies.

Chinese clinical oncology
2020-08-14 | Journal article
DOI: 10.21037/cco-20-69
PMID: 32819110
Source: Self-asserted source
Antonio Bahena-Gonzalez

Validation of the Mexican-Spanish Version of the EORTC QLQ-OV28 Instrument for the Assessment of Quality of Life in Women with Ovarian Cancer.

Archives of medical research
2020-08-05 | Journal article
DOI: 10.1016/j.arcmed.2020.07.004
PMID: 32768148
Source: Self-asserted source
Antonio Bahena-Gonzalez

Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients.

Translational oncology
2019-12-20 | Journal article
DOI: 10.1016/j.tranon.2019.11.003
PMID: 31869745
PMC: PMC6931216
Source: Self-asserted source
Antonio Bahena-Gonzalez

Experiencia con el uso de olaparib en pacientes con cáncer de ovario.

Gaceta medica de Mexico
2019-01-01 | Journal article
DOI: 10.24875/gmm.19005494
PMID: 31787769
Source: Self-asserted source
Antonio Bahena-Gonzalez

Acute liver failure associated with levetiracetam and lacosamide combination treatment for unspecified epileptic disorder.

Case reports in emergency medicine
2013-08-20 | Journal article
DOI: 10.1155/2013/634174
PMID: 24027645
PMC: PMC3762071
Source: Self-asserted source
Antonio Bahena-Gonzalez
How many people are using ORCID?